Literature DB >> 1489135

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.

E J Miller1, A B Cohen, S Nagao, D Griffith, R J Maunder, T R Martin, J P Weiner-Kronish, M Sticherling, E Christophers, M A Matthay.   

Abstract

The adult respiratory distress syndrome (ARDS) is characterized by increased neutrophils within the airspaces of the lungs. In order to determine if neutrophil activating protein (NAP)-1/interleukin-8 (NAP-1/IL-8) could be an important cause of neutrophil influx and activation in ARDS, we examined fluid, which was either directly aspirated or lavaged with saline from the lungs of patients with ARDS. NAP-1/IL-8 was present in significantly higher concentrations in the fluids of patients with ARDS compared with control subjects. There was a significant correlation between the percentage of neutrophils in the lavage fluids and the NAP-1/IL-8 concentration (r2 = 0.74). Furthermore, the NAP-1/IL-8 concentration of the pulmonary edema fluid was equivalent to the optimal concentration required to induce neutrophil chemotaxis in vitro. Although not all of the chemotactic activity of the edema fluid was removed by an anti-NAP-1/IL-8 affinity column, the data established that NAP-1/IL-8 is an important neutrophil chemotaxin in the airspaces of patients with ARDS. In addition, those patients with very high concentrations of NAP-1/IL-8 in their bronchoalveolar lavage fluids had a higher mortality rate than those patients with lower concentrations of NAP-1/IL-8. The correlation between NAP-1/IL-8 concentration and mortality is not paralleled by total protein concentration and mortality.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489135     DOI: 10.1164/ajrccm/146.2.427

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  106 in total

1.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Vedang Londhe; Ying Ying Xue; Kewang Li; Roderick J Phillips; Robert M Strieter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC).

Authors:  Laurie E Kilpatrick; Stephen W Standage; Haiying Li; Nichelle R Raj; Helen M Korchak; Marla R Wolfson; Clifford S Deutschman
Journal:  J Leukoc Biol       Date:  2010-08-19       Impact factor: 4.962

3.  Predictors of mortality in mechanically ventilated patients.

Authors:  T D Sudarsanam; L Jeyaseelan; K Thomas; G John
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

4.  Progress toward the total synthesis of frondosin C.

Authors:  Xin Li; Robert E Kyne; Timo V Ovaska
Journal:  Org Lett       Date:  2006-10-26       Impact factor: 6.005

5.  The 3'-untranslated region of human interleukin-8 mRNA suppresses IL-8 gene expression.

Authors:  Y Yu; K Chadee
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

6.  Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment.

Authors:  Y Zhang; B F Ramos; B Jakschik; M P Baganoff; C L Deppeler; D M Meyer; D L Widomski; D J Fretland; M A Bolanowski
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

7.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

8.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.

Authors:  H G Folkesson; M A Matthay; C A Hébert; V C Broaddus
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Menthol in electronic cigarettes: A contributor to respiratory disease?

Authors:  Vijayalekshmi Nair; Malcolm Tran; Rachel Z Behar; Song Zhai; Xinping Cui; Rattapol Phandthong; Yuhuan Wang; Songqin Pan; Wentai Luo; James F Pankow; David C Volz; Prue Talbot
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-17       Impact factor: 4.219

10.  A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS.

Authors:  Zhaoxi Wang; Douglas Beach; Li Su; Rihong Zhai; David C Christiani
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-18       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.